Press Releases ReproCELL Incorporated

Equities

4978

JP3974770004

Market Closed - Japan Exchange Other stock markets 07:00:00 21/05/2024 BST			5-day change	1st Jan Change
133 ^JPY	-0.75%		+0.76%	-24.00%

2023	ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd.	CI
2023	ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clinical Trials: An Evolutionary Perspective	18/01/23	PU
ReproCELL Incorporated : 4 ways ex vivo models offer Pharma better alternatives to animal testing	31/10/22	PU
ReproCELL Incorporated : How human fresh tissue models are helping RCD405 achieve regulatory approval	17/08/22	PU
ReproCELL Incorporated : Everything we know about the 5HT1B receptor	21/04/22	PU
ReproCELL Incorporated : Skin biopsy and ex vivo culture methods	29/03/22	PU
ReproCELL Incorporated : The influence of the microbiome on inflammatory bowel diease	18/03/22	PU
ReproCELL Incorporated : What is Human Tissue Testing?	14/03/22	PU
ReproCELL Incorporated : co-author paper with IBM showcasing a novel ML driven precision medicine strategy for drug development	08/03/22	PU
ReproCELL Incorporated : Solutions for Skin Disease Researchers	04/03/22	PU
ReproCELL Incorporated : Predicting Psoriasis Drug Efficacy in Human Skin	03/03/22	PU
ReproCELL Incorporated : How SynFire® Technology can benefit your research	03/03/22	PU
ReproCELL Incorporated : Inserts or plates for your 3D cell culture?	28/02/22	PU
ReproCELL Incorporated : How to improve your 3D Cell Culture using Small-scale Perfusion Systems	15/02/22	PU
ReproCELL Incorporated : Biotechgate Digital Partnering 2022 7 - 11 February 2022 • Virtual Meeting	10/02/22	PU
ReproCELL Incorporated : Enhance your epithelial barriers assay using Alvetex	07/02/22	PU
ReproCELL Incorporated : spotlights the power of smarter biospecimens in new global publication	20/01/22	PU
ReproCELL Incorporated : Everything you need to know about the REPROCELL iPSC Biobank	30/11/21	PU
ReproCELL Incorporated : How we established an in vitro Parkinson’s Disease model	24/11/21	PU
ReproCELL Incorporated : What is Human Tissue Testing?	14/10/21	PU
ReproCELL Incorporated : How digital PCR can improve CRISPR gene editing (with examples)	05/10/21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ReproCELL Incorporated

Equities

4978

JP3974770004

Press Releases

Filters